Skip to main content

Systemic Lupus Erythematosus

  • Chapter
Principles of Molecular Medicine

Abstract

Lupus is a serious, potentially life-threatening disease. Its natural history is to culminate in a crescendo of autoimmunity and organ involvement. Difficulty arriving at the diagnosis may delay institution of therapy, which although helpful brings new problems. The fundamental understanding of this disease has made major strides. There is no consensus on the likely etiological agent(s), though evidence implicates Epstein-Barr virus, and the genetic approach to understanding etiology is in its infancy. Nevertheless, efficacious treatments are anticipated in the plethora of new biologics likely to have therapeutic effects in lupus, essentially a disease of immune dysregulation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 269.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 349.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected References

  • Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998;41(10):1714–1724.

    Article  PubMed  CAS  Google Scholar 

  • Golan TD, Elkon KB, Gharavi AE, Krueger JG. Enhanced membrane binding of autoantigens to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation J Clin Invest 1992;90:1067–1076.

    Article  PubMed  CAS  Google Scholar 

  • Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren’s syndrome. Science 1986;232:1145–1147.

    Article  PubMed  CAS  Google Scholar 

  • James JA, Harley JB, Scofield RH. Role of viruses in systemic lupus erythe-matousus and Sjögren’s syndrome. Curr Opin Rheum 2001;13:370–376.

    Article  CAS  Google Scholar 

  • James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B( derived PPPGMRPP and PPPGIRGP induced spliceosome autoimmunity. J Exp Med 1995;181:453–461.

    Article  PubMed  CAS  Google Scholar 

  • James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJA, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997;100:3019–3026.

    PubMed  CAS  Google Scholar 

  • Kawashima T, Zappi EG, Lieu TS, Sontheimer RD. Impact of ultraviolet radiation on the cellular expression of Ro/SS-A-autoantigenic polypeptides. Dermatology 1994;189:6–10.

    Article  PubMed  Google Scholar 

  • Kelly JA, Moser KL, Harley JB. The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun 2002;3(Suppl 1): S71–S85.

    Article  PubMed  CAS  Google Scholar 

  • Molina H. Update on complement in the pathogenesis of systemic lupus erythematosus. Curr Opin Rheum 2002;14:492–497.

    Article  CAS  Google Scholar 

  • Reichlin M. Autoantibodies to the RoRNP particles. Clin Exp Immunol 1995;99(1):7–9.

    Article  PubMed  CAS  Google Scholar 

  • Richardson B. DNA methylation and autoimmune disease. Clin Immunol 2003;109:72–79.

    Article  PubMed  CAS  Google Scholar 

  • Sawalha AH, Richardson BC. DNA methylation in the pathogenesis of systemic lupus erythematosus. Current Pharmacogenomics 2005;3:73–78.

    Article  CAS  Google Scholar 

  • Smoller BR, Horn TD. Lupus erythematosus. In: Smoller BR, Horn TD, eds. Dermatopathology in Systemic Disease, 1st ed. New York: Oxford, 2001, pp. 3–16.

    Google Scholar 

  • Sontheimer RD, Provost TT. Lupus erythematosus. In: Sontheimer RD, Provost TT, eds. Cutaneous Manifestations of Rheumatic Diseases, 1st ed. Baltimore: Williams and Wilkins, 1996, pp. 1–71.

    Google Scholar 

  • Srivastava M, Rencic A, Diglio G, et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol 2003;139:45–49.

    Article  PubMed  CAS  Google Scholar 

  • Wallace D. Management of lupus erythematosus: recent insights. Curr Opin Rheum 2002;14:212–219.

    Article  CAS  Google Scholar 

  • Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J immunol 1995;154:3025–3035.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.

About this chapter

Cite this chapter

Sawalha, A.H., Diaz, L.A., Harley, J.B. (2006). Systemic Lupus Erythematosus. In: Runge, M.S., Patterson, C. (eds) Principles of Molecular Medicine. Humana Press. https://doi.org/10.1007/978-1-59259-963-9_99

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-963-9_99

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-202-5

  • Online ISBN: 978-1-59259-963-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics